Skip to main content
. 2019 Oct 15;58(4):417–424. doi: 10.1093/mmy/myz103

Table 1.

Demographic and baseline clinical characteristics, and associated survival.

Survival
Characteristic N = 36 n (%) Day 42 n (%)a Day 84 n (%)a
Age, years:
 Median (range) 51 (3–82) NA NA
 <18 3 (8.3) 3 (100) 3 (100)
Male sex 21 (58.3) 14 (66.7) 13 (61.9)
Underlying conditions:
 Hematologic malignancy 17 (47.2) 12 (70.6) 9 (52.9)
  Allogeneic HCT 5 (13.9) 3 (60.0) 2 (40.0)
 Use of corticosteroids 9 (25.0) 9 (100) 8 (88.9)
 Neutropenia 9 (25.0) 7 (77.8) 6 (66.7)
 Diabetes mellitus 5 (13.9) 4 (80.0) 4 (80.0)
 Solid organ transplant 3 (8.3) 3 (100) 2 (66.7)
 Penetrating trauma 2 (5.6) 2 (100) 2 (100)
 Otherb 4 (11.1) 4 (100) 4 (100)
 None (at time of initial infection)c 5 (13.9) 4 (80.0) 4 (80.0)

Data are proportion (%) of patients, unless otherwise specified. Underlying condition counts total to more than 36, because patients may have more than one underlying condition.

HCT = hematopoietic stem cell transplantation, NA = not applicable.

aPercentages are numbers of patients with the characteristic who were alive at day 42 or day 84/total numbers with the characteristic.

bIncludes one each of: cell-mediated immune deficiency (uncontrolled), Crohn's disease, interstitial lung disease, and systemic lupus erythematosus.

cIncludes patients who had infections caused by Cryptococcus gattii (three), Exophiala species (one), and Paracoccidioides brasiliensis (one).